All filters
Slidesets
Behrens, Georg - Clinical case #1
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Slidesets
Cliona Ni Cheallaigh | Clinical Case #2: Patient with Immune Non-Response
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Slidesets
Dr. Marcus Altfeld | Immune Non-Responders - A Remaining Unmet Need
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Slidesets
Dr. Daniel Kuritzkes | Update on Clinical Trials of Drugs for Patients with Limited Treatment Options
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Slidesets
Anna Maria Geretti | Epidemiology of Patients with Limited Treatment Options in Europe
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Slidesets
Andrea Calcagno | Pharmacological Considerations in Optimizing Care for Patients with Limited Treatment Options
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Videos
A Phase 3, Open-label, Dose Escalation study to determine the pharmacokinetics of Atazanavir administered with RIfampicin to HIV positive adults on sEcond-line ART regimen with suppressed HIV-1 viral load (DERIVE): Scheduled Interim Analysis
Presenter: Sandra Grañana Castillo
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Videos
Drug-Drug Interactions in Hospitalized COVID-19 Patients Receiving Investigational Drugs (CATCO-DDI)
Presenter: Nancy Sheehan
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Videos
Low-level viremia is associated with lower cumulative adherence to antiretroviral therapy in persons with HIV
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Using PBPK modelling to estimate lamivudine exposure in children with abnormal kidney function
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Charles Boucher Memorial Lecture
Antiviral PK 2021 Charles Boucher Memorial Lecture Day 3 | 22 September Title: Tribute to Charles Boucher's Contributions to this Program and HIV Research Presenter: Jonathan Schapiro
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
John Gerber Memorial Lecture
Antiviral PK 2021 Session: John Gerber Memorial Lecture Day 1 | 20 September Presenter: David Back
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Transporters Expression in Brain and Other Tissues I Session: John Gerber Memorial Lecture
Antiviral PK 2021 Title: Transporters Expression in Brain and Other Tissues Session: John Gerber Memorial Lecture Day 1 | 20 September Presenter: Reina Bendayan
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Applications and Challenges of ML and AI for Pharmacogenomics
Antiviral PK 2021 Session 4: Innovative Approaches for Antiviral Pharmacology Day 2 | 21 September Title: Applications and Challenges of ML and AI for Pharmacogenomics Presenter: Dennis Wang
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Imaging Drug Disposition in Tissues for PK/PD
Antiviral PK 2021 Session 4: Innovative Approaches for Antiviral Pharmacology Day 2 | 21 September Title: Imaging Drug Disposition in Tissues for PK/PD Presenter: Elias Rosen
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Debate: TAF versus TDF - TDF Advocate
Antiviral PK 2021 Session 5: Debate: TAF versus TDF Day 2 | 21 September Title: Debate: TAF versus TDF - TDF Advocate Presenter: José Castillo Mancilla
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
LA Controversies: Need for Oral Lead-In and How to Cover Tail of Injectable LA Regimens
Antiviral PK 2021 Session 7: Live Panel Discussion on LA Day 2 | 21 September Title: LA Controversies: Need for Oral Lead-In and How to Cover Tail of Injectable LA Regimens Presenter: Charles Flexner
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Special Populations Including End Organ Failure: Focus on Long-Acting Cabotegravir and Rilpivirine
Antiviral PK 2021 Session 7: Live Panel Discussion on LA Day 2 | 21 September Title: Special Populations Including End Organ Failure: Focus on Long-Acting Cabotegravir and Rilpivirine Presenter: Parul Patel
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
DDIs
Antiviral PK 2021 Session 7: Live Panel Discussion on LA Day 2 | 21 September Title: DDIs Presenter: Catia Marzolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Pharmacological Considerations for Special Populations
Antiviral PK 2021 Session 8: Pharmacological Considerations for Special Populations Day 3 | 22 September Title: PrEP Benchmarks – Can They Cover All Populations – Pregnancy? Presenter: Peter Anderson
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Immune Checkpoint Inhibitors in the Treatment of HBV
Antiviral PK 2021 Session 8: Pharmacological Considerations for Special Populations Day 3 | 22 September Title: Immune Checkpoint Inhibitors in the Treatment of HBV Presenter: Debika Bhattacharya
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Pharmacologically Focused to Optimize HIV Prevention for Transgender Women
Antiviral PK 2021 Session 8: Pharmacological Considerations for Special Populations Day 3 | 22 September
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Charles Boucher Memorial Lecture
Antiviral PK 2021 | Charles Boucher Memorial Lecture | Angela Kashuba
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Small Molecules and mAbs as Antiviral Therapy for COVID-19
Antiviral PK 2021 Session 1: Clinical Pharmacology of COVID-19 Day 1 | 20 September
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021